QC
EW icon

Quent Capital’s Edwards Lifesciences EW Stock Holding History

Quent Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Sell
1,491
-148
-9% -$12.2K 0.01% 498
2025
Q4 		$140K Sell
1,639
-97
-6% -$7.96K 0.01% 469
2025
Q3 		$135K Buy
+1,736
New +$136K 0.01% 359
2025
Q2 		– Sell
-1,551
Closed -$112K – 599
2025
Q1 		$112K Buy
1,551
+72
+5% +$5.15K 0.01% 366
2024
Q4 		$109K Sell
1,479
-36
-2% -$2.52K 0.01% 382
2024
Q3 		$100K Sell
1,515
-317
-17% -$23K 0.01% 505
2024
Q2 		$169K Buy
1,832
+77
+4% +$6.82K 0.02% 342
2024
Q1 		$168K Sell
1,755
-248
-12% -$20.8K 0.02% 364
2023
Q4 		$153K Buy
2,003
+459
+30% +$31.9K 0.02% 355
2023
Q3 		$107K Sell
1,544
-10
-0.6% -$804 0.02% 391
2023
Q2 		$147K Buy
1,554
+28
+2% +$2.43K 0.02% 343
2023
Q1 		$126K Buy
1,526
+160
+12% +$12.6K 0.02% 366
2022
Q4 		$102K Sell
1,366
-145
-10% -$11.2K 0.02% 401
2022
Q3 		$125K Buy
1,511
+106
+8% +$10.2K 0.03% 326
2022
Q2 		$134K Buy
1,405
+234
+20% +$24.2K 0.03% 297
2022
Q1 		$138K Buy
1,171
+508
+77% +$57K 0.03% 351
2021
Q4 		$86K Buy
+663
New +$77.3K 0.02% 434

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quent Capital's EW Position: Q1 2026 in Review

Quent Capital reduced its Edwards Lifesciences (EW) stake by 9% in Q1 2026, selling an estimated $12.2K and leaving 1,491 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #498.

Quent Capital first reported a position in EW in Q4 2021 and has held it in 17 quarters since. The position peaked at $169K in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Quent Capital held 1,491 shares of Edwards Lifesciences worth $119K as of Q1 2026.
  • Quent Capital sold 148 Edwards Lifesciences shares in Q1 2026, an estimated $12.2K.
  • Edwards Lifesciences made up 0.01% of Quent Capital's portfolio in Q1 2026, its #498 holding.
  • Quent Capital first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Edwards Lifesciences position peaked at $169K in Q2 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.